BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11114102)

  • 1. Insulin receptor substrate (IRS) transduction system: distinct and overlapping signaling potential.
    Giovannone B; Scaldaferri ML; Federici M; Porzio O; Lauro D; Fusco A; Sbraccia P; Borboni P; Lauro R; Sesti G
    Diabetes Metab Res Rev; 2000; 16(6):434-41. PubMed ID: 11114102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
    Valverde AM; Lorenzo M; Pons S; White MF; Benito M
    Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of insulin receptor substrate 3 with SH2 domain-containing proteins in rat adipocytes.
    Ross SA; Lienhard GE; Lavan BE
    Biochem Biophys Res Commun; 1998 Jun; 247(2):487-92. PubMed ID: 9642156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defects of the insulin receptor substrate (IRS) system in human metabolic disorders.
    Sesti G; Federici M; Hribal ML; Lauro D; Sbraccia P; Lauro R
    FASEB J; 2001 Oct; 15(12):2099-111. PubMed ID: 11641236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IRS-pathway operates distinctively from the Stat-pathway in hematopoietic cells and transduces common and distinct signals during engagement of the insulin or interferon-alpha receptors.
    Uddin S; Fish EN; Sher D; Gardziola C; Colamonici OR; Kellum M; Pitha PM; White MF; Platanias LC
    Blood; 1997 Oct; 90(7):2574-82. PubMed ID: 9326223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The new elements of insulin signaling. Insulin receptor substrate-1 and proteins with SH2 domains.
    Myers MG; White MF
    Diabetes; 1993 May; 42(5):643-50. PubMed ID: 8387037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of binding proteins to IRS-1 in insulin signalling.
    Ogawa W; Matozaki T; Kasuga M
    Mol Cell Biochem; 1998 May; 182(1-2):13-22. PubMed ID: 9609110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of insulin-induced signal transduction mediated by the insulin receptor substrate family.
    Kaburagi Y; Yamauchi T; Yamamoto-Honda R; Ueki K; Tobe K; Akanuma Y; Yazaki Y; Kadowaki T
    Endocr J; 1999 Mar; 46(Suppl):S25-34. PubMed ID: 12054114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSM, an insulin-dependent, pro-rich, PH, SH2 domain containing partner of the insulin receptor.
    Riedel H; Wang J; Hansen H; Yousaf N
    J Biochem; 1997 Dec; 122(6):1105-13. PubMed ID: 9498552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IRS-signalling system in insulin and cytokine action.
    White MF
    Philos Trans R Soc Lond B Biol Sci; 1996 Feb; 351(1336):181-9. PubMed ID: 8650265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IRS-signalling system: a network of docking proteins that mediate insulin action.
    White MF
    Mol Cell Biochem; 1998 May; 182(1-2):3-11. PubMed ID: 9609109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues.
    Thirone AC; Carvalho CR; Saad MJ
    Endocrinology; 1999 Jan; 140(1):55-62. PubMed ID: 9886807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional characterization of insulin receptor substrate proteins and the molecular mechanisms of their interaction with insulin superfamily tyrosine kinase receptors and effector proteins.
    Shpakov AO; Pertseva MN
    Membr Cell Biol; 2000; 13(4):455-84. PubMed ID: 10926366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells.
    Ariga M; Nedachi T; Akahori M; Sakamoto H; Ito Y; Hakuno F; Takahashi S
    Biochem J; 2000 Jun; 348 Pt 2(Pt 2):409-16. PubMed ID: 10816436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the Shb SH2 domain-protein in insulin-producing cells leads to altered signaling through the IRS-1 and IRS-2 proteins.
    Welsh N; Makeeva N; Welsh M
    Mol Med; 2002 Nov; 8(11):695-704. PubMed ID: 12520086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of IRS-2 in insulin and cytokine signalling.
    Sun XJ; Wang LM; Zhang Y; Yenush L; Myers MG; Glasheen E; Lane WS; Pierce JH; White MF
    Nature; 1995 Sep; 377(6545):173-7. PubMed ID: 7675087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
    Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
    Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylinositol 3'-kinase associates with an insulin receptor substrate-1 serine kinase distinct from its intrinsic serine kinase.
    Cengel KA; Kason RE; Freund GG
    Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):397-404. PubMed ID: 9761740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common and distinct elements in insulin and PDGF signaling.
    Myers MG; Cheatham B; Fisher TL; Jachna BR; Kahn CR; Backer JM; White MF
    Ann N Y Acad Sci; 1995 Sep; 766():369-87. PubMed ID: 7486683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin receptor substrate polymorphisms and type 2 diabetes mellitus.
    Sesti G
    Pharmacogenomics; 2000 Aug; 1(3):343-57. PubMed ID: 11256583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.